US 9029525
Compositions and methods for inhibiting expression of GSK-3 genes
granted A61PA61P21/00A61P25/00
Quick answer
US patent 9029525 (Compositions and methods for inhibiting expression of GSK-3 genes) held by Alnylam Pharmaceuticals, Inc. expires Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Alnylam Pharmaceuticals, Inc.
- Grant date
- Tue May 12 2015 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 07 2035 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 23
- CPC classes
- A61P, A61P21/00, A61P25/00, A61P25/16, A61P25/18